Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

Abstract Details

Iron Metabolism Patterns in Non-anemic Myasthenia Gravis Patients: A Cross-sectional and Follow-up Study
Neuromuscular and Clinical Neurophysiology (EMG)
P1 - Poster Session 1 (8:00 AM-9:00 AM)
10-010

Recent evidence has indicated that iron metabolism disorders might be prominent in neuroimmune diseases including multiple sclerosis, polymyositis, dermatomyositis, etc. Nonetheless, few published studies investigated iron metabolism pattern in MG patients and factors associated with it. 

The primary objectives of the study were to compare iron metabolism patterns between non-anemic immunotherapy-naïve MG patients and healthy controls as well as between the same group of MG patients before and after receiving immunotherapy, and to identify predictors associated with iron metabolism abnormalities in these patients.

One hundred and five patients and healthy individuals were included at baseline, after which paired parametric and non-parametric tests were adopted to compare their iron metabolism patterns, and multivariate binary logistic regression was used to identify predictors for iron metabolism disorders. MG patients were then followed-up for (12 ± 3) months to explore alterations in their iron metabolism patterns with paired tests.

Non-anemic immunotherapy-naïve MG patients had significantly lower serum iron (SI) and transferrin saturation (TS) levels compared with healthy individuals. Premenopausal female was significantly associated with SI < 65 μg/dL and iron deficiency in these patients. Iron metabolism parameters did not alter significantly after receiving immunotherapy for around 12 months in MG patients.

Iron inadequacy was present in MG patients, particularly premenopausal female ones, and would hardly improve after immunotherapy. Given the essential role of iron in human body, it should be given more attention in MG patients.

Authors/Disclosures
Ke Li, MD
PRESENTER
Dr. Li has nothing to disclose.
Li’an Hou (PUMCH) No disclosure on file
Ying Tan, MD Dr. Tan has nothing to disclose.
Yangyu Huang, MD Dr. Huang has nothing to disclose.
Jiayu Shi No disclosure on file
Jianhua Han Mrs. Han has nothing to disclose.
Jing Yang No disclosure on file
Yuzhou Guan No disclosure on file